Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
Clinical trial NCT07558850 · RECRUITING
Trial details
- NCT number
- NCT07558850
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-10
- Primary completion
- 2028-01-10
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.